<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/030/SRR13200730/SRR13200730.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/020/SRR13200720/SRR13200720.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/026/SRR13200726/SRR13200726.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/028/SRR13200728/SRR13200728.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/031/SRR13200731/SRR13200731.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/027/SRR13200727/SRR13200727.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/029/SRR13200729/SRR13200729.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/025/SRR13200725/SRR13200725.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/021/SRR13200721/SRR13200721.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/022/SRR13200722/SRR13200722.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/024/SRR13200724/SRR13200724.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR132/023/SRR13200723/SRR13200723.fastq.gz</Fastqsanger.gz></files><type>primary</type></body><statusCodeValue>200</statusCodeValue><statusCode>OK</statusCode></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>Experimental and Molecular Pathology, Institute of Pathology, Ludwig-Maximilians-University Munich</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA682642</full_dataset_link><scientific_name>Homo sapiens</scientific_name><long_description>We studied the effect of CRISPR/Cas9-mediated deletion of LINC01021 on genome-wide RNA expression changes after ectopic activation of p53 in CRC cells by RNA-Seq analyses Overall design: RNA expression profiles with and without ectopic activation of p53 in colorectal cancer cells with and without deletion of LINC01021</long_description><tag>xref:PubMed:38730591</tag><repository>ENA</repository><description_synonyms>beta[[3]]-Tub, DmelCG17117, dp53, Clr, p50, p53, Gene, 143391_i_at, beta3 TU, F20O9_210, LFS1, betaTub3, autosomal dominant, Tp53, l(3)05745, colorectal cancer, DMP53, dATF-4, bbl, anon-EST:Liang-2.17, Cell., Dmp53, anon-EST:Liang-2.11, clone 2.11, anon-EST:Liang-2.13, Atf4, 929, DmelCG8669, 1323/07, clone 2.13, Gene Expressions, Genomes, BCC7, clone 2.17, D.m.BETA-60D, beta-Tub6D, dmp53, Scrb1, CG9429, F20O9.210, T, DmP53, 1422/04, CRUCIFERIN C, Ire1, Expressions, large intestine cancer, cancer of the large intestine, B3t, DmelCG3401, Trp53, Dp53, vartul, betaTub60C, beta3-tubulin, beta[[3]]-tubulin, Expression, TRP53, CG17117, somatic mutation, p50/tubulin, colorectal (colon or rectal) cancer, beta-Tub60D, CG10873, Dmbeta3, Dm-HTH, SCRIB1, BETA 60D, potp, prac, beta3t, beta3-Tub, eth, Xp53, 3t, p53/tubulin, bfy, Crc, CRC, l(2)crc, beta[[3]] tubulin, Tub60D, anon-EST:fe3D7, HTH, Hth, large bowel cancer, CG33336, beta-tub, cruciferin 3, susceptibility to, DmelCG33336, D-p53, beta60C, CG3401, beta3Tub, beta3TUB, Dm-P53, l(3)86Ca, crc, whole genome, beta3, CRIB, cancer of large bowel, dtl, Tub, DTB3, ATF-4, DmelCG9429, Meis1, hth1, crt, colon cancer, hth2, betatub60D, P53, p44, cancer of the large bowel, bhy, CG8669, cancer of large intestine, mKIAA0147, ATF4/crc, CG31325, betaTub, AI118201</description_synonyms><name_synonyms>beta[[3]]-Tub, DmelCG17117, dp53, Clr, p50, p53, Gene, 143391_i_at, beta3 TU, F20O9_210, LFS1, betaTub3, autosomal dominant, Tp53, l(3)05745, colorectal cancer, DMP53, dATF-4, bbl, anon-EST:Liang-2.17, Cell., Dmp53, anon-EST:Liang-2.11, clone 2.11, anon-EST:Liang-2.13, Atf4, 929, DmelCG8669, 1323/07, clone 2.13, Gene Expressions, Genomes, BCC7, clone 2.17, D.m.BETA-60D, beta-Tub6D, dmp53, Scrb1, CG9429, F20O9.210, T, DmP53, 1422/04, CRUCIFERIN C, Ire1, Expressions, large intestine cancer, cancer of the large intestine, B3t, DmelCG3401, Trp53, Dp53, vartul, betaTub60C, beta3-tubulin, beta[[3]]-tubulin, Expression, TRP53, CG17117, somatic mutation, p50/tubulin, colorectal (colon or rectal) cancer, beta-Tub60D, CG10873, Dmbeta3, Dm-HTH, SCRIB1, BETA 60D, potp, prac, beta3t, beta3-Tub, eth, Xp53, 3t, p53/tubulin, bfy, Crc, CRC, l(2)crc, beta[[3]] tubulin, Tub60D, anon-EST:fe3D7, HTH, Hth, large bowel cancer, CG33336, beta-tub, cruciferin 3, susceptibility to, DmelCG33336, D-p53, beta60C, CG3401, beta3Tub, beta3TUB, Dm-P53, l(3)86Ca, crc, whole genome, beta3, CRIB, cancer of large bowel, dtl, Tub, DTB3, ATF-4, DmelCG9429, Meis1, hth1, crt, colon cancer, hth2, betatub60D, P53, p44, cancer of the large bowel, bhy, CG8669, cancer of large intestine, mKIAA0147, ATF4/crc, CG31325, betaTub, AI118201</name_synonyms></additional><is_claimable>false</is_claimable><name>Genome-wide characterization of effects of LINC01021 on p53-regulated gene expression in CRC cells</name><description>Genome-wide characterization of effects of LINC01021 on p53-regulated gene expression in CRC cells</description><dates><last_updated>2025-09-24</last_updated><first_public>2024-05-17</first_public></dates><accession>PRJNA682642</accession><cross_references><GEO>GSE162710</GEO><taxon>9606</taxon><PubMed>38730591</PubMed></cross_references></HashMap>